Efficacy and Safety of 2% and 4% Articaine for Lower Third Molar Surgery
- PMID: 26202994
- DOI: 10.1177/0022034515596313
Efficacy and Safety of 2% and 4% Articaine for Lower Third Molar Surgery
Abstract
This double-blind crossover randomized clinical trial compared the efficacy of 2 concentrations of articaine, 2% (A2) and 4% (A4), with 1:200,000 epinephrine, for lower third molar removal. During 2 separate appointments with either A2 or A4, both similarly positioned lower third molars in 46 volunteers were extracted. The following were evaluated: onset and duration of anesthetic action on soft tissues, intraoperative bleeding, hemodynamic parameters, postoperative analgesia, and mouth opening and wound healing during the 7th postoperative day, along with the incidence, type, and severity of adverse reactions. Nearly identical volumes of both anesthetic solutions were used for each appointment: 3.4 ± 0.9 mL ≈ 68 mg of articaine (A2) and 3.3 ± 0.8 mL ≈ 132 mg of articaine (A4). Statistical analysis indicated no differences in onset or duration of anesthetic action on soft tissues or duration of postoperative analgesia evoked by A2 and A4 anesthetic solutions (P > 0.05). The surgeon's rating of intraoperative bleeding was considered minimal throughout all surgery with both anesthetic solutions. While transient changes in blood pressure, heart rate, and oxygen saturation were observed, these factors were clinically insignificant and were uninfluenced by articaine concentration (P > 0.05). No systemic or local adverse reactions were observed in the preoperative and postoperative periods due to A2 or A4, but 1 case of bilateral paresthesia was observed. There were no significant differences between preoperative and postoperative (7th day) values of mouth opening and wound healing whether volunteers received A2 or A4 (P > 0.05). In conclusion, both A2 and A4, administered in equal volumes, were effective and safe during lower third molar surgery, and no significant differences were found between their efficacy and safety (ClinicalTrials.gov NCT02457325).
Keywords: epinephrine; hemodynamics; inferior alveolar nerve block; local anesthesia; pain; trismus.
© International & American Associations for Dental Research.
Similar articles
-
A comparison of the clinical anesthetic efficacy of 4% articaine and 0.5% bupivacaine (both with 1:200,000 epinephrine) for lower third molar removal.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Jul;106(1):19-28. doi: 10.1016/j.tripleo.2007.11.024. Epub 2008 Apr 16. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008. PMID: 18420431 Clinical Trial.
-
Epinephrine concentration (1:100,000 or 1:200,000) does not affect the clinical efficacy of 4% articaine for lower third molar removal: a double-blind, randomized, crossover study.J Oral Maxillofac Surg. 2007 Dec;65(12):2445-52. doi: 10.1016/j.joms.2007.04.020. J Oral Maxillofac Surg. 2007. PMID: 18022467 Clinical Trial.
-
Articaine and mepivacaine efficacy in postoperative analgesia for lower third molar removal: a double-blind, randomized, crossover study.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Aug;102(2):169-74. doi: 10.1016/j.tripleo.2005.09.003. Epub 2006 Mar 24. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006. PMID: 16876058 Clinical Trial.
-
Articaine hydrochloride: is it the solution?Dent Update. 2015 Jan-Feb;42(1):88-90, 92-3. doi: 10.12968/denu.2015.42.1.88. Dent Update. 2015. PMID: 26062283 Review.
-
Anesthetic Efficiency of Articaine Versus Lidocaine in the Extraction of Lower Third Molars: A Meta-Analysis and Systematic Review.J Oral Maxillofac Surg. 2019 Jan;77(1):18-28. doi: 10.1016/j.joms.2018.08.020. Epub 2018 Sep 5. J Oral Maxillofac Surg. 2019. PMID: 30267700
Cited by
-
Multifocal Analysis of Acute Pain After Third Molar Removal.Front Pharmacol. 2021 Apr 15;12:643874. doi: 10.3389/fphar.2021.643874. eCollection 2021. Front Pharmacol. 2021. PMID: 33935738 Free PMC article.
-
Volume and effectiveness assessment of articain 4% versus mepivacaine 2% used in third molar surgery: randomized, double-blind, split-mouth controlled clinical trial.Med Oral Patol Oral Cir Bucal. 2020 Nov 1;25(6):e762-e768. doi: 10.4317/medoral.23780. Med Oral Patol Oral Cir Bucal. 2020. PMID: 32701928 Free PMC article. Clinical Trial.
-
Why choose articaine over lidocaine for the removal of third molars? Systematic review and meta-analysis.J Clin Exp Dent. 2023 Nov 1;15(11):e963-e977. doi: 10.4317/jced.60682. eCollection 2023 Nov. J Clin Exp Dent. 2023. PMID: 38074170 Free PMC article. Review.
-
Efficacy of piroxicam for postoperative pain after lower third molar surgery associated with CYP2C8*3 and CYP2C9.J Pain Res. 2017 Jul 6;10:1581-1589. doi: 10.2147/JPR.S138147. eCollection 2017. J Pain Res. 2017. PMID: 28740425 Free PMC article.
-
On the Relationship Between White Matter Structure and Subjective Pain. Lessons From an Acute Surgical Pain Model.Front Hum Neurosci. 2020 Nov 24;14:558703. doi: 10.3389/fnhum.2020.558703. eCollection 2020. Front Hum Neurosci. 2020. PMID: 33328926 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical